Aberdeen Group plc purchased a new stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 101,100 shares of the medical instruments supplier’s stock, valued at approximately $13,137,000.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Ranger Investment Management L.P. purchased a new stake in Mesa Laboratories during the 2nd quarter worth approximately $17,321,000. Diamond Hill Capital Management LLC Investment Advisor purchased a new stake in shares of Mesa Laboratories during the second quarter worth $15,507,000. William Blair Investment Management LLC purchased a new position in Mesa Laboratories in the 3rd quarter worth approximately $16,934,000. Wasatch Advisors LP boosted its holdings in Mesa Laboratories by 125.8% in the 2nd quarter. Wasatch Advisors LP now owns 115,668 shares of the medical instruments supplier’s stock valued at $11,515,000 after purchasing an additional 64,435 shares during the last quarter. Finally, Bank of New York Mellon Corp acquired a new stake in Mesa Laboratories in the 2nd quarter valued at approximately $4,540,000. 90.60% of the stock is owned by hedge funds and other institutional investors.
Mesa Laboratories Stock Up 2.4%
Mesa Laboratories stock opened at $137.81 on Thursday. The firm’s fifty day moving average is $129.65 and its 200 day moving average is $107.10. Mesa Laboratories, Inc. has a 12-month low of $69.62 and a 12-month high of $144.35. The company has a market capitalization of $774.49 million, a PE ratio of 17.85 and a beta of 1.08. The company has a quick ratio of 1.39, a current ratio of 1.90 and a debt-to-equity ratio of 0.65.
Mesa Laboratories Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Monday, November 30th will be given a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 0.5%. The ex-dividend date is Monday, November 30th. Mesa Laboratories’s dividend payout ratio (DPR) is presently 56.14%.
Analysts Set New Price Targets
Several analysts have recently weighed in on MLAB shares. Weiss Ratings raised Mesa Laboratories from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, October 8th. Wall Street Zen upgraded Mesa Laboratories from a “buy” rating to a “strong-buy” rating in a research report on Saturday, October 3rd. Jefferies Financial Group raised their price target on Mesa Laboratories from $125.00 to $150.00 and gave the stock a “buy” rating in a research note on Tuesday, November 10th. Finally, Wells Fargo & Company lifted their target price on shares of Mesa Laboratories from $94.00 to $110.00 and gave the company an “equal weight” rating in a report on Friday, August 14th. One research analyst has rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, Mesa Laboratories has an average rating of “Hold” and a consensus price target of $130.00.
Get Our Latest Stock Report on MLAB
Mesa Laboratories Profile
Mesa Laboratories, Inc. develops and manufactures instruments and consumable products used to monitor and control quality in life sciences and other regulated industries. Its offerings support activities such as sterilization and disinfection monitoring, laboratory testing, biopharmaceutical development, and equipment calibration. The company’s products include biological and chemical indicators, data loggers, calibration instruments, and tools used in clinical genomics and bioprocessing. Customers use these products to help verify processes, measure conditions, and meet quality requirements.
Further Reading
- Five stocks we like better than Mesa Laboratories
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Want to see what other hedge funds are holding MLAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report).
Receive News & Ratings for Mesa Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
